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Abstract Current antibiofilm solutions based on plank-
tonic bacterial physiology have limited efficacy in clinical
and occasionally environmental settings. This has promp-
ted a search for suitable alternatives to conventional ther-
apies. This study compares the inhibitory properties of two
biological surfactants (rhamnolipids and a plant-derived
surfactant) against a selection of broad-spectrum antibiot-
ics (ampicillin, chloramphenicol and kanamycin). Testing
was carried out on a range of bacterial physiologies from
planktonic and mixed bacterial biofilms. Rhamnolipids
(Rhs) have been extensively characterised for their role in
the development of biofilms and inhibition of planktonic
bacteria. However, there are limited direct comparisons
with antimicrobial substances on established biofilms
comprising single or mixed bacterial strains. Baseline
measurements of inhibitory activity using planktonic bac-
terial assays established that broad-spectrum antibiotics
were 500 times more effective at inhibiting bacterial
growth than either Rhs or plant surfactants. Conversely,
Rhs and plant biosurfactants reduced biofilm biomass of
established single bacterial biofilms by 74–88 and
74–98 %, respectively. Only kanamycin showed activity
against biofilms of Bacillus subtilis and Staphylococcus
aureus. Broad-spectrum antibiotics were also ineffective
against a complex biofilm of marine bacteria; however, Rhs
and plant biosurfactants reduced biofilm biomass by 69 and
42 %, respectively. These data suggest that Rhs and plant-
derived surfactants may have an important role in the
inhibition of complex biofilms.
Introduction
Microbial biofilms have been implicated in recalcitrant
healthcare-associated infections [24, 28, 47], the dissemi-
nation of community-acquired diseases [43] and hazardous
concerns in the nutritional and environmental sectors [23].
Biofilms are sessile multicellular bacterial collectives with
distinctly different physiologies from those of independent
free-living bacteria [8]. Many biofilms are resistant to con-
ventional antimicrobial technologies that were developed
using a planktonic model [30]. In an effort to compensate for
enhanced biofilm resistance, therapeutic doses of conven-
tional antibiotics are often increased, accelerating harmful
resistance patterns in bacteria. The detrimental conse-
quences of this in the human population and wider envi-
ronment have prompted a search for alternative solutions.
One such safe and effective alternative to synthetic medi-
cines and antimicrobial agents are biosurfactants [3, 18, 38].
Rhamnolipids (Rhs) are a group of biosurfactants pro-
duced by Pseudomonas aeruginosa. These have one (for
mono-rhamnolipid) or two (for di-rhamnolipids) rhamnose
sugar moieties (hydrophilic moiety) acylated to long-chain
fatty acids or hydroxyl fatty acids (hydrophobic moiety)
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through one or two b-hydroxy fatty acid chains [32]. Their
characteristic antimicrobial activity (mostly against
planktonic bacteria) and biomedical applications have been
extensively investigated [3, 4, 7, 13, 37]. However, there is
surprisingly little information available on the extent to
which Rhs and plant biosurfactants (PBs) inhibit mixed-
species pre-existing bacterial biofilms. The inhibitory
activity of several different Rh mixtures has been docu-
mented in relation to pre-existing single-species biofilms of
Salmonella typhimurium [27], Bordetella bronchiseptica
[16], microflora on vocal prosthesis [39] and Bacillus
pumilus [10]. However, these studies have not examined
this inhibitory action in direct comparison to existing
antimicrobial solutions. Mixed bacterial biofilms are also
important in inhibitory tests because many biofilms exist as
complex polymicrobial colonisations [20, 41, 42, 46]. This
complexity can add another dimension to their persistence
[41]. In order to encompass a wide range of biofilm phy-
siologies, this study compared the action of the biosur-
factants with broad-spectrum antimicrobials on mixed
bacterial biofilms.
Materials and Methods
Chemicals and Reagents
All solvents of analytical grade or other purities were
supplied by VWR (HiPerSolv, Chromanorm Range, VWR
international, Poole, Dorset, UK). Microbiological media
and reagents were supplied by Oxoid Ltd (Basingstoke,
Hampshire, UK) unless otherwise stated. Nutrient broth:
Lab-Lemco Powder (1.0 g), yeast extract (2.0 g), peptone
(5.0 g) and sodium chloride (5.0 g).
Broad-spectrum antibiotics: ampicillin (AMP) and kana-
mycin (KAN) were supplied by Gibco (Paisley, Scotland,
UK) and chloramphenicol (CHL) was supplied by Acros
(Geel, Belgium).
Rhs (at a 4 % w/v concentration, containing mono- and
di-rhamnolipids mixtures) were produced as described previ-
ously [32, 35] and were diluted from a stock of 2 mg/ml
solution.
The PB (SC1000) was supplied by Biobased Europe,
Ayrshire, Scotland (http://www.biobasedeurope.com/).
This is a non-ionic surfactant blend of plant oil extracts,
fatty alcohols and tall oil. This colloid is water soluble and
readily biodegradable and was formulated from a stock
concentration of 2 mg/ml.
Bacterial Strains and Culture Conditions
Bacterial strains included Escherichia coli (ATTC 11775),
Citrobacter freundii (ATTC 8090), Klebsiella pneumoniae
(ATTC 13883), Cronobacter sakazkii (ATTC 29544),
Micrococcus luteus (ATTC 4698), Bacillus subtilis (ATTC
6051) and Staphylococcus aureus (ATTC 12600). Bacteria
for all experiments were removed from frozen stocks (-80 C
in glycerol) and thawed when necessary. Bacteria were cul-
tured at 37 C in nutrient broth (Oxoid Ltd) and enumerated
by transferring an aliquot (10 ll) of growing bacteria to
nutrient agar (NA) and incubating overnight at 37 C.
Minimum Inhibitory Concentration
Minimum inhibitory concentrations (MICs) for planktonic
bacteria were assessed using flat-bottomed 96-well high-
bind plates (Costar , Corning Incorporated, Corning, NY,
USA). To maintain consistent comparisons throughout bio-
film analysis, all assays and dilutions were performed using
nutrient broth. This meant that the analysis did not require
media supplements for different species or adjustments for
test substances such as broad-spectrum antibiotics. The
highest concentration of the biosurfactant (test substance)
was diluted through a series of twofold dilutions in 10 wells
of a 96-well plate. To ensure that the MIC was within the
range of observations, pilot experiments were carried out to
determine the optimal range of concentrations for the test
biosurfactant. The same determinations were also performed
for the broad-spectrum antibiotics AMP, CHL and KAN. For
MIC determinations, a 1-ml aliquot of bacteria that was sub-
cultured (18 h at 37 C) in sterile nutrient broth was incu-
bated for a further 2–3 h in 50 ml of fresh media. The
inoculum was adjusted to 1 9 104 cfu (determined from a
growth curve for each bacterium in comparison to their OD
at (600 nm)) and added to a 96-well plate. Appropriate
controls of test substance only and media only were also
added to wells in the same plate. Cultures along with test
substances were shaken (130 rpm) overnight at 37 C. The
MIC was determined as the lowest concentration of test
substance that inhibited visual growth of test bacteria after
overnight incubation (16–20 h). Broth was removed from
wells that showed visual inhibition and inoculated onto NA.
The minimum concentration of test substance resulting in no
bacterial growth was referred to as the minimum bactericidal
concentration (MBC).
Radial Diffusion Assay
A modification of the ultrasensitive radial diffusion assay
(RDA) was used to detect inhibitory activity of test sub-
stances on solid growth media [33, 21].
Preparation of Single-Species Biofilms
Single-species (homogenous) biofilms were prepared to
assess the inhibition by biosurfactant in comparison to
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broad-spectrum antibiotics [33]. Biofilm biomass was
quantified by the crystal violet adhesion assay, commonly
used in biofilm quantification [18, 25, 27, 33, 34]. The
absorbance values were expressed as a percentage of a
control biofilm for each organism, which contained an
identical concentration of bovine serum albumin (BSA)
(Sigma, St Louis, MO, USA). Most antibiotics and bio-
surfactants are also a potential carbon source for bacteria;
therefore, BSA was used as the control substance due to its
relatively benign nature in terms of bacterial inhibitory
activity [6].
Preparation of Self-Assembling Marine Biofilm
(SAMB)
A self-assembling marine biofilm (SAMB) was used to
compare the ability of broad-spectrum antibiotics and
biosurfactants to disperse a complex mixture of bacteria.
This consisted of an assemblage of marine bacteria that
formed a mixed marine bacterial biofilm (which was sub-
sequently characterised in terms of species composition) on
high-bind 99-well polystyrene plates [33]. Mixed biofilms
were cultivated at a low temperature (10 C) in a dilute
nutrient medium of 50 % nutrient broth and 50 % seawa-
ter. Test substances were added to the four-day-old SAMB
and subsequently cultivated for 4 days. The supernatant in
the test well, referred to as planktonic bacteria, was
removed from the wells. The biofilm biomass was quanti-
fied using the crystal violet adherence assay.
DNA-Based Characterisation of the SAMB: Cloning
After allowing the SAMB to form for 8 days, DNA was
extracted from attached organisms constituting the biofilm.
The biofilm was rinsed three times with sterile PBS to
remove loosely associated bacteria prior to DNA extraction
using a Power Biofilm kit (MO BIO Laboratories Inc.,
Carlsbad, California, USA). DNA was PCR amplified with
each 50-ll reaction containing PCR buffer at 19, 1.5 mM
MgCl2, 0.8 lM of universal primers U519F and U1068R
[2, 45], 200 lM of each deoxynucleoside triphosphate,
1.25 U HotStar Taq polymerase (Qiagen, Hilden, Germany)
and 1.5 ll of DNA. Reactions was run under the following
conditions: 10 min at 95 C, followed by 28 cycles of 45-s
denaturing (95 C), 45-s annealing (55 C), 1-min elonga-
tion (72 C) and an additional 10-min elongation at 72 C.
Four replicate PCRs were pooled, purified (MinElute Kit,
Qiagen, Hilden, Germany) and 20 ng of PCR products were
cloned using a TOPO-TA (Invitrogen) cloning kit. Recom-
binant clones were screened to ensure they were carrying
inserts of the correct size prior to purification (QIAprep
Miniprep kit, Qiagen, Hilden, Germany) and 53
plasmids were commercially sequenced (Beckman-Coulter
Genomics, Essex, UK) using the primer U519F. Sequence
reads were manually edited and aligned using Geneious Pro
software version 5.5.6 (Geneious, Auckland, New Zealand).
Sequences were analysed using the CLASSIFIER tool
available through the Ribosomal Database Project [44].
Neighbouring sequences were used to reconstruct phyloge-
netic associations based on the neighbour-joining method
with Tamura–Nei distances [40].
Data Analysis
Statistical analysis was performed using GraphPad Prism 4
software (Hearne Scientific Software Pty Ltd, Melbourne,
Victoria, Australia). For MIC/MBC, data were given as
mean ± standard error of the mean (SEM). For RDA test,
the radius of inhibition (mm) was annotated as mean ±
SEM for each test bacteria. For the calculations of the
inhibition of single species of microbial biofilm, absorbance
values (at 595 nm) from crystal violet adherence assay of
control wells were subtracted from test wells to give a cor-
rected value. This corrected value was expressed as a per-
centage of the control biofilm. The significance of corrected
values relative to the control was calculated using a two-
tailed students t test (unpaired) and annotated as *P \ 0.05,
**P \ 0.01 and ***P \ 0.001. Outlying absorbance values
that were less than the value of a standard blank well (i.e. a
negative absorbance value in the crystal violet adherence
assay) were adjusted using the value of a blank well, which
was assigned as 0.01. Absorbance values from the test sub-
stances were expressed as a percentage of the control/control
biofilm and used to create a bar graph depicting the
mean ± SEM. This procedure was also followed for the
mixed-species marine biofilm.
Results and Discussion
A comparison of solutions to bacterial colonisation cannot
be adequately assessed through exclusively planktonic
bacterial assays. In this manuscript, the efficacy of a Rh, a
PB, AMP, KAN and CHL was compared over a range of
bacterial physiologies. These included planktonic, agar
(stranded planktonic), single-species biofilms and mixed-
species bacterial biofilms [26].
Comparisons of the Minimum Inhibitory
Concentrations of Antibiotics and Biosurfactants
Although bacteria exploit optimal growth conditions, there
are very few environments in which they receive the optimum
nutrition, agitation and aeration provided by laboratory-based
planktonic culture. Rather, research suggests that many bac-
teria assume a more sessile physiology typified by a biofilm in
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a more nutrient-poor environment [8]. However, in order to
establish a baseline for inhibitory comparisons, the MIC and
the MBC of antibiotics and biosurfactant were determined for
mid-logarithmic cultures of common, medically relevant
organisms: E. coli, M. luteus and S. aureus. The test sub-
stances used were AMP, CHL and KAN together with bio-
surfactants (Rh and a PB). Test substances were incubated
with a predefined amount of bacteria as detailed in the
methods section and incubated overnight at 37 C at 130 rpm.
The resulting MIC/MBC data indicated that of the sur-
face-active agents, only the PB had inhibitory activity
against E. coli. However, wells containing Rh showed broad
inhibitory activity against M. luteus and S. aureus (Table 1).
The activity of these biosurfactants was weak in comparison
to the broad-spectrum antibiotics AMP, KAN and CHL
(Table 1). In some instances, the difference in MIC was
1:1,024 broad-spectrum antibiotics/biosurfactants, (based on
individual replicate data). Additionally, the determination of
the MIC for the Pb was slightly problematic given its opaque
nature; however, it was assumed that the MIC should not be
greater than the MBC and values were annotated accord-
ingly. The antimicrobial effects of biosurfactants and in
particular Rhs on planktonic bacteria have been noted as far
back as 1971 [17]. However, different species of bacteria
can vary widely in their sensitivity to inhibitory compounds
even between strains of the same species [31], therefore
standard laboratory strains were compared under controlled
experimental conditions. The MIC for Rhs observed in
Table 1 varied with different microorganisms and was
generally higher for Gram-negative E. coli strain ([200 lg/
ml) and lower for Gram-positive M. luteus (29 lg/ml) and
S. aureus (50 lg/ml). This was supported by previous
research on S. aureus (ATCC 6538) which had an observed
MIC for Rhs at 32 lg/ml and the MIC for E. coli (ATTC
8739) and M. luteus (9631) was 64 lg/ml (mixture of 11
congeners) tested for 24 h (37 C) [13]. More recent
research has comparable MICs of [512 lg/ml for E. coli
(ATTC 25922), 32–64 lg/ml for M. luteus and 128 lg/ml
for S. aureus (ATTC 29213) [22]. The slightly higher MIC
readings in these experiments may have been due to slower
rotational incubation (130 rpm) of cultures necessitated by
the depth of the microplate wells or a slightly difference in
the composition of the Rhs components. Although there are
few direct comparisons of the effects of Rhs with broad-
spectrum antibiotics, independent measurements on the MIC
of E. coli (ATTC 11775) support our observations with
average MIC ranges recorded from 2 to 25 lg/ml [29, 36].
Radial Diffusion Assay
Another form of the planktonic physiology can be descri-
bed as stranded planktonic growth and is routinely used
when antibiotics are tested on agar plates [26]. This was
also used to compare the inhibitory properties of the bio-
surfactants against the broad-spectrum antibiotics. Given
the weak nature of the biosurfactant inhibition of growth in
the previous planktonic tests, a modification of an ultra-
sensitive inhibition assay was used [21]. Biosurfactants
(20 lg) and broad-spectrum antibiotics (5 lg) were applied
to wells in NA and the test substances absorbed into the
agar for two hours. The different concentrations of test
substances reflect the greater potency of the broad-spec-
trum antibiotics in this experiment. These ratios were
maintained through the proceeding experiments in order
that comparisons between inhibitory potentials could be
made. Predefined inoculums of test bacteria (B. subtilis, C.
sakazakii, S. aureus, E. coli, M. luteus and K. pneumoniae)
were added to the agar plates and these were incubated
overnight (37 C). The inhibition data indicated that
although both Rhs and the Pb possessed antimicrobial
activity *1/12 to 1/24 as effective as the broad-spectrum
antibiotics AMP, CHL and KAN (when dilution factors
were taken into account) (Fig. 1), the biosurfactant had
some inhibitory activity against Gram-positive bacteria, but
was ineffective against Gram-negative bacteria (Fig. 1).
The data also show that on this occasion, the difference in
the inhibition between the biosurfactant and the broad-
spectrum antibiotics was less than the MIC determinations.
These observations are supported by research using con-
centrations of 10–30 mg/ml Rh resulting in zones of inhi-
bition of 15–20 mm for S. aureus (ATCC 25922) and no
inhibition for E. coli [22].
Single-Species Biofilm Assay
It has been demonstrated that the pre-addition of biosur-
factants can successfully inhibit the formation of biofilms
in fungi [9], S. typhimurium [27], B. bronchiasepta [16],
orally associated flora [39] and the marine bacteria
B. pumilus [10]. However, a more realistic scenario is the
application of biosurfactants to pre-existing biofilms
[9, 10]. Therefore, biosurfactants and broad-spectrum
antibiotics were incubated with biofilms of B. subtilis,
M. luteus and S. aureus at similar concentrations to the
previous RDA to enable a direct comparison between
experiments. A 10-ll aliquot of biosurfactants (total con-
centration of 20 lg) and broad-spectrum antibiotics (total
concentration of 5 lg) (ampicillin, chloramphenicol and
kanamycin) was added to biofilms that had been cultivated
for two days. The biofilm biomass was quantified by the
crystal violet adherence assay. This assay was used for
quantification because it allows for the measurement of
both cell growth and biofilm biomass.
The quantification data revealed that the addition of the
Rh and the Pb to pre-existing biofilms reduced S. aureus
biofilm biomass by 85.6 ± 3.9 and 83.3 ± 6.1 %,
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respectively (P \ 0.001, n = 12). AMP and CHL did not
significantly affect the biofilm biomass (P [ 0.05, n = 12)
and KAN had some inhibitory activity against S. aureus
(34.7 ± 10.8 %) (Fig. 2a).
In the case of pre-existing biofilms of B. subtilis,
the biofilm biomass was reduced by 88.4 ± 5.8 and
98.1 ± 1.7 % by Rhs and Pb, respectively (P \ 0.001,
n = 12) (Fig. 2b). The addition of AMP produced no
significant inhibition, whilst CHL increased the biofilm
biomass by 54.8 ± 20.3 % (P \ 0.05) and KAN
decreased it by 39.3 ± 9.5 % (P \ 0.01, n = 12)
(Fig. 2b). The addition of Rh to pre-existing biofilms of
Table 1 Comparison of minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC) in planktonic culture of
biosurfactants and broad-spectrum antibiotics
MIC (lg/ml) MBC (lg/ml)
Rh PB AMP CHL KAN Rh PB AMP CHL KAN
E. coli
11775
[200 133 ± 33.3 10.4 ± 2.1 3.1 0.5 ± 0.1 [200 133 ± 33.3 [25 [25 1.3 ± 0.3
M. luteus
4698
29.2 ± 11.0 116.7 ± 44.1 0.8 ± 0.4 2.1 ± 0.5 3.1 ± 1.6 150 ± 50 116.7 ± 44.1 1.3 ± 0.3 3.6 ± 1.4 4.7 ± 1.6
S. aureus
12600
50 133.3 ± 33.3 0.5 ± 0.1 3.1 3.1 [200 133.3 ± 33.3 0.6 ± 0.1 6.2 3.1
Rhamnolipids Rh and a plant biosurfactant PB were incubated with a defined inoculum of a: E. coli; b: M. luteus; and c: S. aureus in comparison
to ampicillin AMP, chloramphenicol CHL and kanamycin KAN. Cultures were incubated overnight on a rotatory shaker at 37 C/130 rpm.
Values are expressed as mean ± standard error of the mean SEM in lg/ml for each test substance, n = 3
Fig. 1 Comparison of
biosurfactants and broad-
spectrum antibiotics in a radial
diffusion assay. Aliquots of
rhamnolipid (Rh) and a plant
biosurfactant (PB) (20 lg/ml),
ampicillin (AMP),
chloramphenicol (CHL) and
kanamycin (KAN) (5 lg/ml)
were assayed in a radial
diffusion assay against a lawn of
a B. subtilis, b C. sakazakii, c S.
aureus, d E. coli, e M. luteus
and f K. pneumoniae. The
inhibition of substances was
determined by the measurement
of the radius of the zone of
inhibition ZOI after overnight
incubation. The values are
recorded as mean inhibition
±SEM (mm), n = 4
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M. luteus reduced biofilm biomass by 74.5 ± 6.6 %
(P \ 0.001, n = 12), whilst that of Pb produced no sig-
nificant effect on the biofilm biomass (P [ 0.05, n = 12)
Fig. 2c). The addition of the broad-spectrum antibiotics,
AMP, CHL and KAN, also produced no significant
reduction in biofilm biomass (Fig. 2c). Biofilm growth
after the addition of antibiotics is of concern and has
been observed by other researchers, initially for amino-
glycosides [15] and then for other antibiotics especially in
sub-MIC doses [19]. This is not surprising given the
microbial origins of the majority of antibiotics.
In contrast, Rh can successfully disperse pre-existing
bacterial biofilms. This has previously been demonstrated
with the marine bacteria, B. pumilus [10]. It has been
reported that the most potent biosurfactant, surfactin, is
capable of dispersing biofilms of S. typhimurium at con-
centrations of 5–50 lg [27]. Given this range, the data
presented here illustrate that the dispersion efficiency of
Rhs on preformed bacterial biofilms is relatively strong.
Further research on S. typhimurium biofilms has revealed
that concentrations of 100 lg of Rh were required (mixture
of 11 congeners) to disperse pre-existing biofilms [27]. It
was therefore noted that even with dilution factors taken
into account, the efficacy of the broad-spectrum antibiotics
declined in comparison to biosurfactants in biofilm assays.
This decrease in efficiency has previously been noted by
the group of Olsen for many antibiotics [7]. However, an
increase in efficiency of biosurfactants from planktonic
growth to biofilm has not been documented as often. Direct
comparisons between planktonic bacterial and biofilm
inhibition data are difficult because biofilm experiments are
difficult to standardise. Each bacterial species, surface of
attachment, temperature variation and nutrient status has
the potential to create a different biofilm dynamic. There-
fore, our experiments used similar reagents and surfaces for
experiments to allow better comparisons.
DNA-Based Characterisation of the Self-Assembling
Marine Biofilm (SAMB)
Although researchers have realized that the biofilm mode
of growth is important in microbial colonisation, there has
been less documentation on polymicrobial biofilms. This
may be due to the multiplicity of potential bacterial per-
mutations and the difficulties assessing the colonisation
and succession patterns in such biofilms. However, it is
know that the mixed biofilm dynamic can add an extra
virulent dimension to some clinical biofilms [41]. Since
there are many unknown factors in the assembly of com-
plex biofilms, a large collection of marine bacteria was
induced to form a mixed biofilm. This was referred to as a
SAMB and subsequently characterised in terms of species
composition (Fig. 3). The characterisation of the SAMB by
cloning revealed a diverse assemblage of bacteria belong-
ing to two phyla, Bacteroidetes and Proteobacteria, and
covering as many as eight genera (Fig. 3 and Supplemen-
tary Table 1). Proteobacteria sequences were the most
frequently observed accounting for 87 % of sequences
recovered. Pseudoalteromonas was the most frequently
observed genera accounting for 51 % of the total sequen-
ces, followed by Oceanisphaera (9 %), Colwellia (6 %)
and Polaribacter (6 %). This illustrates an extremely wide
diversity in the biofilm. There has been some research on
the construction of test biofilms composed of two species
Fig. 2 Comparison of biosurfactants and broad-spectrum antibiotics
on established single-species biofilms. Aliquots (10 ll) of rhamnoli-
pids (Rh), a plant biosurfactant (PB) (total 20 lg), ampicillin (AMP),
chloramphenicol (CHL) and kanamycin (KAN) (total 5 lg) were
added apically to homogenous bacterial biofilms that had been
cultivated for 2 days. The biofilms were a B. subtilis, b M. luteus and
c S. aureus. After a further 2 days of incubation, the biofilms were
quantified using the crystal violet adhesion assay. Quantification of
biofilm biomass was in comparison to the control biofilm (B) which
consisted of BSA ? bacteria. Biofilm dispersal values were annotated
as mean ± SEM, n = 4–12. A two-tailed students t test was used to
determine if test biofilms significantly differed from the control
biofilm of the same species (*P \ 0.05, **P \ 0.01, ***P \ 0.001)
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and also biofilms with up to 5 species [14, 41]. However,
the complex biofilm systems such as SAMB [33] are not
frequently documented and were originally designed to
study the pathogenicity of cryptosporidium [48].
Self-Assembling Marine Biofilm Assay
The comparison of efficiency of antibiotics and biosur-
factants against SAMB was addressed as follows. A 10 ll
aliquot of biosurfactants (total added 20 lg) and broad-
spectrum antibiotics (total added 5 lg) (ampicillin, chlor-
amphenicol and kanamycin) was applied to a pre-existing
biofilm of SAMB after 4 days of incubation at low tem-
peratures as described in methods. The biofilms were
incubated for a further 4 days before quantification of the
biofilm biomass by crystal violet adherence assay.
The quantification indicated that the addition of
Rhs to pre-existing SAMB reduced biofilm biomass by
Fig. 3 Phylogenetic association based on partial 16S rRNA gene
sequences of bacteria used in inhibition assays. Type strains (TS) used
in the minimum inhibitory assay, radial diffusion assay, homogeneous
biofilm (HB) inhibition tests and sequences cloned from the SAMB
are depicted along with neighbouring sequences (followed by a
GenBank accession no.). The SAMB entries are followed by a
number indicating the total number of sequences recovered. Vertical
black and grey bars indicate the represented Phyla and Classes,
respectively. The Neighbour-joining method with Tamura–Nei
distances was used for tree construction. Scale bar is equal to base
pair substitutions per site
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69.0 ± 3.4 % (P \ 0.001, n = 4) relative to the control
biofilm. The Pb reduced biofilm biomass by 26.5 ± 2.6 %
relative to this control (P \ 0.05, n = 4). The addition of
AMP, CHL and KAN had no significant inhibitory effect
on the biofilms relative to the growth of the control biofilm
(P [ 0.05, n = 4) (Fig. 4). The ratio of inhibition was
*5:1, biosurfactant/broad-spectrum antibiotic. Taking into
account the fourfold dilution of the broad-spectrum anti-
biotics, this result shows a dramatic reversal of the effec-
tiveness of the biosurfactants from the initial planktonic
tests to the mixed biofilm assays. Similar experiments
using a lipopeptide biosurfactant complex containing
fusaricidins and polymyxins on a preformed biofilm of
mixed marine organisms achieved a 72.4 % reduction of
biofilm biomass [33]. Further observations on the marine
bacteria B. pumilus showed that Rhs could disperse pre-
formed biofilms by 93 % at a concentration of 100 mM
[10]. Although the biofilm used here was of marine origin
and the dispersal of its heterogeneous terrestrial counter-
parts has yet to be experimentally verified, the data dem-
onstrate the great potential of Rhs to disperse mixed
bacterial biofilms.
The mechanisms of biofilm inhibition by Rhs were not
within the scope of this investigation; however, previous
work suggests that biosurfactants are effective in biofilm
dispersal because of their depletion of extracellular poly-
meric substances [10], their integral role in the biofilm
cycle [5], promotion of cell surface hydrophobicity [1, 11]
and their ability to overcome the theoretically low
wettability of preformed biofilms [12]. Whether these
mechanisms are exactly the same for mixed complexes of
bacteria has yet to be experimentally verified.
Conclusions
After establishing a baseline for the comparison of bio-
surfactants and antimicrobial agents, the data have indi-
cated that the inhibitory effect of biosurfactants increases
drastically in comparison to broad-spectrum antibiotics in
biofilm-orientated assays. Additionally, through the use of
the SAMB, it was observed that the biosurfactants inhibited
the formation of complex heterogeneous marine biofilms.
This suggests that biosurfactants such as these may be able
to play an important role in the development of solutions to
single and mixed biofilms or even act as adjuvants to
existing therapies aimed at tackling biofilm formation or
eliminating established biofilms.
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